In vitro proliferation capacity and killing efficacy of CIK cells from umbilical cord blood versus patients with chronic hepatitis B

In vitro proliferation capacity and killing efficacy of CIK cells from umbilical cord blood versus patients with chronic hepatitis B

ObjectiveTo observe the in vitro proliferation capacity and killing efficacy of cytokine-induced killer (CIK) cells from umbilical cord blood (UCB) and versus chronic hepatitis B (CHB) patients of different ages. MethodsFive samples of UCB from healthy fetuses born in our hospital from January to De...

Full description

Bibliographic Details
Main Author:	LIU Liwei
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2014-09-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	hepatitis B chronic; fetal blood; killer cells; cell proliferation; immunocompetence
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=6004&ClassID=86133151

Similar Items

Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B
by: LIU Bo
Published: (2014-09-01)

Researche Advances on CIK Cells and Their Clinical Use in Lung Cancer
by: Hu LUO, et al.
Published: (2011-12-01)

In vitro proliferation and differentiation of hepatic oval cells and their potential capacity for intrahepatic transplantation
by: Z. Li, et al.
Published: (2013-08-01)

Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect
by: Xi Zhou, et al.
Published: (2021-06-01)

Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells
by: J.C. Shu, et al.
Published: (2009-12-01)

Influence of DC-CIK in advanced colorectal cancer patients on T lymphocyte subsets and cytokines
by: Rong Wang, et al.
Published: (2016-07-01)

Hemopoietic and Lymphoid Progenitor Cells in HumanUmbilical Cord Blood
by: F. M. Cicuttini, et al.
Published: (1994-01-01)

Biological Characteristics and Antitumor Activity of CIK Cells Activated by Recombinant Human Fibronectin for Human Lung Cancer Cell Lines In Vitro
by: Jialing WANG, et al.
Published: (2010-04-01)

Efficacy assessment of DC-CIK immunotherapy combined with TACE and RFA treatment of primary hepatocellular carcinoma
by: Xin-Hua Zuo, et al.
Published: (2016-02-01)

Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
by: Paul Kupke, et al.
Published: (2021-09-01)

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections
by: David F. G. Malone, et al.
Published: (2017-05-01)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
by: Frederic Carsten Schmeel, et al.
Published: (2014-08-01)

Bocavirus Viremia and Hepatitis in an Immunocompetent Child
by: Zeliha Haytoğlu, et al.
Published: (2017-06-01)

NATURAL KILLER T CELLS IN HEPATIC LEUCOCYTE INFILTRATES IN PATIENTS WITH MALIGNANT PROCESS AND VIRAL HEPATITIS
by: O. V. Lebedinskaya, et al.
Published: (2014-07-01)

Regulatory effect of natural killer cells on hepatic stellate cells and their role in liver fibrosis
by: LI Tianyang, et al.
Published: (2017-03-01)

A clinical study of autologous cytokine-induced killer cells in treatment of patients with chronic hepatitis B
by: WANG Shaoyang
Published: (2015-04-01)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
by: Ma Yue, et al.
Published: (2012-04-01)

Hematopoietic-Specific Deletion of Foxo1 Promotes NK Cell Specification and Proliferation
by: Pei Huang, et al.
Published: (2019-05-01)

A case report of disseminated herpes simplex hepatitis masquerading as spinal headache
by: Natalia Lattanzio, et al.
Published: (2020-05-01)

Characteristics and prognosis of hepatic cytomegalovirus infection in children: 10 years of experience at a university hospital in Korea
by: Chae-Yeon Min, et al.
Published: (2017-08-01)

Interferon therapy shifts natural killer subsets among egyptian patients with chronic hepatitis C
by: Amal Fathy, et al.

Assessment of serum tumor markers, tumor cell apoptosis and immune response in patients with advanced colon cancer after DC-CIK combined with intravenous chemotherapy
by: Lei-Fan Li, et al.
Published: (2016-12-01)

Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on Ⅲ Stage Non-small Cell Lung Cancer
by: Guangqiang ZHAO, et al.
Published: (2009-09-01)

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
by: Meng‐Jia Song, et al.
Published: (2021-01-01)

Interaction and Mutual Activation of Different Innate Immune Cells Is Necessary to Kill and Clear Hepatitis C Virus-Infected Cells
by: Volker Klöss, et al.
Published: (2017-09-01)

Does the time between collecting and processing umbilical cord blood samples affect the quality of the sample?
by: Ricardo Barini, et al.
Published: (2011-06-01)

Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections
by: Julia Pollmann, et al.
Published: (2017-05-01)

Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
by: Benjamin H. Goldenson, et al.
Published: (2020-10-01)

A juggernaut of innate & adaptive immune cells in chronic hepatitis C
by: Shallu Tomer, et al.
Published: (2020-01-01)

Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients
by: Takeji Umemura, et al.
Published: (2021-06-01)

Three obstetric factors should be considered in umbilical cord blood donor selection
by: Škorić Dejan, et al.
Published: (2020-01-01)

The role of natural killer cells and CD8+ T cells in hepatitis B virus infection
by: Anita eSchuch, et al.
Published: (2014-06-01)

The role of immune system in development of structural changes in colonic mucosa in diverticulosis
by: Svetlana Vladimirovna Levchenko, et al.
Published: (2011-02-01)

Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver
by: Muench Marcus, et al.
Published: (2002-01-01)

Correlation of peripheral blood NK cell content with tumor marker content and proliferation molecule expression in patients with nonsmall cell lung cancer
by: Hui Zhao, et al.
Published: (2017-04-01)

Induction of hepatic tissues in multicellular spheroids composed of murine fetal hepatic cells and embedded hydrogel beads
by: Wakako Motoyama, et al.
Published: (2016-03-01)

Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population
by: Eduardo Delabio Auer, et al.
Published: (2020-07-01)

Helicobacter cinaedi Hepatic Cyst Infection with Bacteremia
by: Tetsuya Suzuki, et al.
Published: (2019-03-01)

Depletion of Thymosin β4 Promotes the Proliferation, Migration, and Activation of Human Hepatic Stellate Cells
by: Yongtao Xiao, et al.
Published: (2014-07-01)

Regulation of proliferation and differentiation of human fetal bone cells
by: N Krattinger, et al.
Published: (2011-01-01)